Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(7%)
Results Posted
43%(3 trials)

Phase Distribution

Ph not_applicable
7
50%
Ph phase_4
5
36%
Ph phase_2
1
7%
Ph phase_3
1
7%

Phase Distribution

0

Early Stage

1

Mid Stage

6

Late Stage

Phase Distribution14 total trials
Phase 2Efficacy & side effects
1(7.1%)
Phase 3Large-scale testing
1(7.1%)
Phase 4Post-market surveillance
5(35.7%)
N/ANon-phased studies
7(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(2)
Completed(7)
Other(5)

Detailed Status

Completed7
unknown5
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (7.1%)
Phase 31 (7.1%)
Phase 45 (35.7%)
N/A7 (50.0%)

Trials by Status

completed750%
recruiting17%
unknown536%
not_yet_recruiting17%

Recent Activity

1 active trials
Showing 5 of 14
recruitingphase_4

Topical TRanexamic Acid vs. Placebo on Acute Postoperative Pain Following DRF Fixation

NCT06384456
not_yet_recruitingnot_applicable

Efficacy of Topical Tranexamic Acid in Reducing Blood Loss During CS in Patients With Placenta Previa

NCT06515535
completednot_applicable

Tranexamic Acid in Pregnant Women Undergoing Cesarean Section.

NCT03778242
unknownnot_applicable

Topical Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Women With Twin Pregnancy

NCT05072873
unknownnot_applicable

Topical Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Women Undergoing Elective Cesarean Section

NCT05072860
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT06384456Phase 4

Topical TRanexamic Acid vs. Placebo on Acute Postoperative Pain Following DRF Fixation

Recruiting
NCT06515535Not Applicable

Efficacy of Topical Tranexamic Acid in Reducing Blood Loss During CS in Patients With Placenta Previa

Not Yet Recruiting
NCT03778242Not Applicable

Tranexamic Acid in Pregnant Women Undergoing Cesarean Section.

Completed
NCT05072873Not Applicable

Topical Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Women With Twin Pregnancy

Unknown
NCT05072860Not Applicable

Topical Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Women Undergoing Elective Cesarean Section

Unknown
NCT03328832Phase 4

Combined Topical Tranexamic Acid With Floseal® in Total Knee Arthroplasty

Completed
NCT03570710Not Applicable

Reducing Blood Loss During Cesarean Hysterectomy for Placenta Accreta Spectrum

Completed
NCT03706339Not Applicable

Reducing Blood Loss During Cesarean Section by Topical Versus IV Tranexamic Acid

Completed
NCT02540226Phase 4

Effect of Topical and Intravenous Tranexamic Acid (TXA) on Thrombogenic Markers in Patients Undergoing Knee Replacement

Completed
NCT01940523Phase 4

Randomized Controlled Trial of Tranexamic Acid in Total Knee Arthroplasty: Intravenous vs. Topical

Completed
NCT03741075Not Applicable

Topical Tranexamic Acid Plus Bilateral Uterine Artery Ligation During Cesarean Delivery

Unknown
NCT03244423Phase 2

Tranexamic Acid in Cyanotic Heart Defects

Completed
NCT02865174Phase 4

Topical Tranexamic Acid and Floseal® in Total Knee Arthroplasty

Unknown
NCT02492087Phase 3

Topical Tranexamic Acid in Caesarean Section

Unknown

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14